Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
0.900
+0.100 (12.50%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Arch Therapeutics Market Cap
Arch Therapeutics has a market cap or net worth of $500.01 thousand as of July 26, 2024. Its market cap has decreased by -87.44% in one year.
Market Cap
500.01K
Enterprise Value
8.53M
1-Year Change
-87.44%
Ranking
n/a
Category
Stock Price
$0.90
Market Cap Chart
Since July 29, 2019, Arch Therapeutics's market cap has decreased from $51.79M to $500.01K, a decrease of -99.03%. That is a compound annual growth rate of -60.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 4.05M | -88.12% |
| Dec 29, 2023 | 34.08M | 424.58% |
| Dec 30, 2022 | 6.50M | -71.13% |
| Dec 31, 2021 | 22.50M | -29.64% |
| Dec 31, 2020 | 31.98M | -31.45% |
| Dec 31, 2019 | 46.65M | -9.93% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 815.29B |
| Novo Nordisk | 578.97B |
| UnitedHealth Group | 509.82B |
| Johnson & Johnson | 370.52B |
| Merck & Co. | 316.73B |
| AbbVie | 306.25B |
| AstraZeneca | 244.97B |
| Thermo Fisher | 214.89B |